Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
640
-
Total 13F shares, excl. options
-
135M
-
Shares change
-
+26.5K
-
Total reported value, excl. options
-
$9.76B
-
Value change
-
-$44.2M
-
Put/Call ratio
-
1.31
-
Number of buys
-
314
-
Number of sells
-
-329
-
Price
-
$72.13
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q1 2022
832 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q1 2022.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 640 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 135M shares
of 176M outstanding shares and own 77.04% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (19.5M shares), VANGUARD GROUP INC (13.2M shares), BAILLIE GIFFORD & CO (10.7M shares), BlackRock Inc. (10.7M shares), Sumitomo Mitsui Trust Holdings, Inc. (8.84M shares), Nikko Asset Management Americas, Inc. (8.45M shares), STATE STREET CORP (3.4M shares), Bank of New York Mellon Corp (2.83M shares), CREDIT SUISSE AG/ (2.25M shares), and BANK OF MONTREAL /CAN/ (2.1M shares).
This table shows the top 640 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.